Frisco, TX (PRWEB) December 07, 2011
The 87th annual Greater New York Dental Meeting (GNYDM) is the largest dentistry meeting in the USA with over 53,000 attendees this year. Greater New York features over 1,000 technical exhibits which demonstrate the newest technology for the dental profession and an extensive education program.
This year was SomnoMed’s inaugural showing successfully creating hundreds of leads and new professional contacts for the company. SomnoMed also hosted a four day sleep education program “Sleep Expo” certifying several hundred new dentists in SomnoDent apnea treatment.
The sleep education program featured esteemed speakers from across the USA including Steve Carstensen, D.D.S, Wesley E. Fleming, M.D, David Schwartz, D.D.S, Nabeel Farah, M.D and Barry Glassman D.D.S. Dr Schwartz commented that “attendees showed tremendous interest in incorporating SomnoDent treatment into their practices, they sense the health care need, the underserved needs of their patients and a potential value added benefit for existing patients.” Dr Glassman who lectured the Advanced Topics courses stated that “It was extremely encouraging to see so many well trained dentists actively seeking additional relevant clinical information”.
SomnoMed, the world’s leading Dental Sleep Medical company had a strong presence on the exhibition floor at the newly created “VIP Lounge”; receiving several hundred of unique enquiries form Greater New York Dental attendees. Ralf Barschow, SomnoMed Limited CEO said that the Greater New York meeting was “the most successful exhibition and educational forum for SomnoMed in terms of new leads and providing premium Dental Sleep Medical education. It was very encouraging to see this overwhelming response after more than 5 years of active presence in the US market with now well over 1,800 active members of the SomnoMed Dental Network, the largest group of professional, and qualified Dental Sleep Medical practices in North America”.
Mr. Barschow commented that “We noticed more companies now trying to enter this newly developing field following our model which will continue to raise the awareness. The limiting factor of growth is the number of qualified and committed dentists to Dental Sleep Medical programs. SomnoMed offers proven, integrated and customized concepts for professional dental practices to become qualified SomnoMed Dental Network affiliates. The time is now for SomnoMed”
SomnoMed is a publicly listed dental sleep medicine company (ASX:SOM) providing diagnostic and treatment solutions for Sleep Breathing Disorders such as Obstructive Sleep Apnea. SomnoMed was commercialized on the basis of extensive clinical research. Supporting independent clinical research, continuous innovation and instituting medical manufacturing standards has resulted in SomnoDent becoming the state-of-the-art and clinically proven medical oral appliance therapy for obstructive sleep apnea. SomnoDent is the most comfortable and effective design and treatment solution for over 70,000 patients in 20 countries. For additional information, visit SomnoMed at http://www.somnomed.com.